Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M412688200 on March 2, 2005

J. Biol. Chem., Vol. 280, Issue 20, 19695-19703, May 20, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/20/19695    most recent
M412688200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller-Podraza, H.
Right arrow Articles by Karlsson, K.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller-Podraza, H.
Right arrow Articles by Karlsson, K.-A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Novel Binding Epitope for Helicobacter pylori Found in Neolacto Carbohydrate Chains

STRUCTURE AND CROSS-BINDING PROPERTIES*

Halina Miller-Podraza{ddagger}§, Boel Lanne{ddagger}, Jonas Ångström{ddagger}, Susann Teneberg, Maan Abul Milh, Per-Åke Jovall, Hasse Karlsson, and Karl-Anders Karlsson

From the Institute of Medical Biochemistry, Göteborg University, P. O. Box 440, SE 40530 Göteborg, Sweden

Helicobacter pylori is a bacterium that colonizes the stomach of a majority of the global human population causing common gastric diseases like ulcers and cancer. It has an unusually complex pattern of binding to various host glycoconjugates including interaction with sialylated, sulfated, and fucosylated sequences. The present study describes an additional binding epitope comprising the neolacto internal sequence of GlcNAc{beta}3-Gal{beta}4GlcNAc{beta}. The binding was detected on TLC plates as an interaction with a seven-sugar ganglioside of rabbit thymus. The glycolipid was purified and characterized as Neu5Gc{alpha}3Gal{beta}4GlcNAc{beta}3Gal{beta}4GlcNAc{beta}3-Gal{beta}4Glc{beta}1Cer with less than 10% of the fraction carrying a repeated lacto (type-1) core chain, Gal{beta}3Glc-NAc{beta}3Gal{beta}3GlcNAc{beta}. After stepwise chemical and enzymatic degradation and structural analysis of products the strongest binder was found to be the pentaglycosylceramide GlcNAc{beta}3Gal{beta}4GlcNAc{beta}3Gal{beta}4Glc{beta}1-Cer, whereas the hexa- and tetraglycosylceramides were less active, and the trihexosylceramide was inactive. Further studies revealed that the terminal GlcNAc{beta} of the pentaglycosylceramide may be exchanged for either GalNAc{beta}3, GalNAc{alpha}3, or Gal{alpha}3 without loss of the activity. Calculated minimum energy conformers of these four isoreceptors show a substantial topographical similarity suggesting that this binding is a result of a molecular mimicry. Although the glycoconjugate composition of human gastric epithelial cells is not known in detail it is proposed that repeating N-acetyllactosamine units of glycoconjugates may serve as bacterial attachment sites in the stomach.


Received for publication, November 9, 2004 , and in revised form, March 2, 2005.

* This work was supported by Swedish Research Council Grant 06X-12628, the Swedish Cancer Foundation, Wilhelm and Martina Lundgrens Research Foundation, the Swedish Medical Society, the Adlerbertska Research Foundation, Ingabritt and Arne Lundberg Foundation, and Symbicom Ltd. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} These authors contributed equally to this work.

Present address: AstraZeneca R&D, S-431 83 Mölndal, Sweden.

§ To whom correspondence should be addressed. Tel.: 46-31-773-3154; Fax: 46-31-416108; Email: Halina.Miller-Podraza{at}medkem.gu.se.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
GlycobiologyHome page
M. Kobayashi, H. Lee, J. Nakayama, and M. Fukuda
Roles of gastric mucin-type O-glycans in the pathogenesis of Helicobacter pylori infection
Glycobiology, May 1, 2009; 19(5): 453 - 461.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
H. Miller-Podraza, K. Weikkolainen, T. Larsson, P. Linde, J. Helin, J. Natunen, and K.-A. Karlsson
Helicobacter pylori binding to new glycans based on N-acetyllactosamine
Glycobiology, April 1, 2009; 19(4): 399 - 407.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement